SG-based AUM Biosciences raises $1.5m in seed funding to develop affordable oncology drugs

Medical drugs in a pharmacy. Credit: Flickr/epSos .de

Singapore-based oncology startup AUM Biosciences has raised $1.5 million (S$2.04 million) in seed funding to develop affordable oncology medicines in Asia. The announcement was made in June this year.

Continue reading this story with a subscription to DealStreetAsia.

Subscribe

Contact us for corporate subscriptions at subs@dealstreetasia.com.